
1. zhongguo xue xi chong bing fang zhi za zhi. 2019 apr 18;31(3):346-348. doi:
10.16250/j.32.1374.2018290.

[progress researches genes associated sulfadoxine-pyrimethamine
resistance plasmodium vivax].

[article chinese; abstract available chinese publisher]

qi-cheng z(1), feng l(1).

author information: 
(1)department parasitology, medical school, yangzhou university, yangzhou
225001, china.

malaria parasitic disease threatens human life health seriously.
sulfadoxine-pyrimethamine (sp) recommended intermittent preventive
treatment malaria children pregnant women, also used compound 
component artemisinin based therapy. mechanisms sp resistance p.
falciparum involve point mutations genes encoding dihydrofolate reductase 
(dhfr) dihydropteroate synthase (dhps), drug pressure also lead
to mutations two genes p. vivax. provide information the
formulation anti-malarial strategies, article reviews discovery,
application, effect sp, resistance mechanism research progress 
the related genes p. vivax.

publisher: [摘要] 疟疾是一种严重威胁人类生命健康的寄生虫病。磺胺多辛-乙胺嘧啶可用于儿童和孕妇疟疾间歇性预防性治 疗,
同时其也作为以青蒿素及其衍生物为基础的联合疗法的一种复方成分而被用于疟疾治疗。恶性疟原虫对磺胺多辛-乙胺嘧啶产生抗药性与编码二氢叶酸还原酶 (dhps)
和二氢蝶酸合酶 (dhfr) 的基因发生点突变相关, 而药物选择压力
亦可导致间日疟原虫上述两个基因发生突变。本文就抗疟药磺胺多辛-乙胺嘧啶的发现、应用、作用和间日疟原虫对其 抗性机制及抗性相关基因研究进展作一综述,
旨在为抗疟策略的制定提供参考依据。.
doi: 10.16250/j.32.1374.2018290 
pmid: 31544425  [indexed medline]

